Variations in peak expiratory flow measurements associated to air pollution and allergic sensitization in children in Sao Paulo, Brazil

Imagem de Miniatura
Arquivos
art_CORREIA-DEUR_Variations_in_peak_expiratory_flow_measurements_associated_to_2012.PDF (386.68 KB)
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2012
Editora
WILEY-BLACKWELL
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
CLAUDIO, Luz
IMAZAWA, Alice Takimoto
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, v.55, n.12, Special Issue, p.1087-1098, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background In the last 20 years, there has been an increase in the incidence of allergic respiratory diseases worldwide and exposure to air pollution has been discussed as one of the factors associated with this increase. The objective of this study was to investigate the effects of air pollution on peak expiratory flow (PEF) and FEV1 in children with and without allergic sensitization. Methods Ninety-six children were followed from April to July, 2004 with spirometry measurements. They were tested for allergic sensitization (IgE, skin prick test, eosinophilia) and asked about allergic symptoms. Air pollution, temperature, and relative humidity data were available. Results Decrements in PEF were observed with previous 24-hr average exposure to air pollution, as well as with 310-day average exposure and were associated mainly with PM10, NO2, and O3 in all three categories of allergic sensitization. Even though allergic sensitized children tended to present larger decrements in the PEF measurements they were not statistically different from the non-allergic sensitized. Decrements in FEV1 were observed mainly with previous 24-hr average exposure and 3-day moving average. Conclusions Decrements in PEF associated with air pollution were observed in children independent from their allergic sensitization status. Their daily exposure to air pollution can be responsible for a chronic inflammatory process that might impair their lung growth and later their lung function in adulthood. Am. J. Ind. Med. 55:10871098, 2012. (c) 2012 Wiley Periodicals, Inc.
Palavras-chave
air pollution, adverse effects, peak expiratory flow, children, allergic sensitization, linear models, PM10, O3, NO2
URI
https://observatorio.fm.usp.br/handle/OPI/714
Referências
  1. Boezen HM, 1999, LANCET, V353, P874, DOI 10.1016/S0140-6736(98)06311-9
  2. Bracken MB, 2002, EPIDEMIOL REV, V24, P176, DOI 10.1093/epirev/mxf012
  3. CETESB (Companhia Ambiental do Estado de Sao Paulo), 2011, QUAL AR EST SAO PAUL
  4. COCHRANE D, 1949, J AM STAT ASSOC, V44, P32, DOI 10.2307/2280349
  5. Dales R, 2009, EUR RESPIR J, V34, P316, DOI 10.1183/09031936.00138908
  6. D'Amato G, 2010, J INVEST ALLERG CLIN, V20, P95
  7. Davies RJ, 1998, CLIN EXP ALLERGY, V28, P8
  8. DREBORG S, 1993, ALLERGY, V48, P473, DOI 10.1111/j.1398-9995.1993.tb01102.x
  9. Epton MJ, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-16
  10. Etzel RA, 2003, PEDIATRICS, V112, P233
  11. Frischer T, 1999, AM J RESP CRIT CARE, V160, P390
  12. Gauderman WJ, 2007, LANCET, V369, P571, DOI 10.1016/S0140-6736(07)60037-3
  13. Gielen MH, 1997, AM J RESP CRIT CARE, V155, P2105
  14. Gold DR, 1999, EPIDEMIOLOGY, V10, P8, DOI 10.1097/00001648-199901000-00004
  15. HE QC, 1993, ARCH ENVIRON HEALTH, V48, P382
  16. He QQ, 2010, RESP MED, V104, P1512, DOI 10.1016/j.rmed.2010.04.016
  17. Holguin F, 2007, AM J RESP CRIT CARE, V176, P1236, DOI 10.1164/rccm.200611-1616OC
  18. Jalaludin BB, 2000, INT J EPIDEMIOL, V29, P549, DOI 10.1093/ije/29.3.549
  19. Jerrett M, 2008, ENVIRON HEALTH PERSP, V116, P1433, DOI 10.1289/ehp.10968
  20. Johnson CC, 2002, EPIDEMIOL REV, V24, P154, DOI 10.1093/epirev/mxf013
  21. Jorres R, 1996, AM J RESP CRIT CARE, V153, P56
  22. Just J, 2002, EUR RESPIR J, V20, P899, DOI 10.1183/09031936.02.00236902
  23. Kramer U, 2000, EPIDEMIOLOGY, V11, P64, DOI 10.1097/00001648-200001000-00014
  24. LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.publhealth.14.1.43
  25. Mannino DM, 2002, CHEST, V122, P409, DOI 10.1378/chest.122.2.409
  26. Morkjaroenpong V, 2002, J ALLERGY CLIN IMMUN, V110, P147, DOI 10.1067/mai.2002.125832
  27. Mortimer KM, 2002, EUR RESPIR J, V19, P699, DOI 10.1183/09031936.02.00247102
  28. NEAS LM, 1995, AM J EPIDEMIOL, V141, P111
  29. Nicolai T, 2003, EUR RESPIR J, V21, P956, DOI 10.1183/09031936.03.00041103
  30. Nicolai T, 2002, TOXICOLOGY, V181, P317, DOI 10.1016/S0300-483X(02)00300-1
  31. Orlando JP, 2010, SCI TOTAL ENVIRON, V408, P1612, DOI 10.1016/j.scitotenv.2009.11.060
  32. POPE CA, 1992, AM REV RESPIR DIS, V145, P1123
  33. POPE CA, 1991, AM REV RESPIR DIS, V144, P668
  34. Romieu I, 1997, ARCH ENVIRON HEALTH, V52, P368
  35. Salvi S, 2001, Curr Opin Allergy Clin Immunol, V1, P35, DOI 10.1097/00130832-200102000-00007
  36. Schwartz J, 2000, AM J RESP CRIT CARE, V161, P802
  37. Trasande L, 2005, J ALLERGY CLIN IMMUN, V115, P689, DOI 10.1016/j.jaci.2005.01.056
  38. van der Zee SC, 1999, OCCUP ENVIRON MED, V56, P802
  39. Viegi G, 2004, INT J TUBERC LUNG D, V8, P1401
  40. Villeneuve PJ, 2006, ALLERGY, V61, P750, DOI 10.1111/j.1398-9995.2006.01070.x
  41. Wamboldt FS, 2002, J PEDIATR-US, V141, P109, DOI 10.1067/mpd.2002.125490
  42. Ward DJ, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2003.007088
  43. Wyler C, 2000, EPIDEMIOLOGY, V11, P450, DOI 10.1097/00001648-200007000-00015
  44. ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734
  45. Kay AB, 2001, NEW ENGL J MED, V344, P30
  46. [Anonymous], 1998, LANCET, V351, P1225

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPR
Artigos e Materiais de Revistas Científicas - LIM/25
Artigos e Materiais de Revistas Científicas - LIM/38